Marketing-authorisation holder · Italy
Zambon S.P.A.
24 medicines in 6 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
24 medicines in 6 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
24 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DORZOLAMIDE HYDROCHLORIDE2% base · Solution/drops | Dorzolamide | United States | Marketed | 2008 |
| EMYLIFFilm orodispersibile | Riluzole | Italy | Authorised | |
| Emylif 50 mg orodispergeerbare filmOrodispergeerbare film | Riluzole | Netherlands | Authorised | 2022 |
| Hopledo 140 mg/35 mg harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard | Carbidopa, Levodopa | Netherlands | Authorised | 2026 |
| Hopledo 210 mg/52,5 mg harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard | Carbidopa, Levodopa | Netherlands | Authorised | 2026 |
| Hopledo 280 mg/70 mg harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard | Carbidopa, Levodopa | Netherlands | Authorised | 2026 |
| Hopledo 350 mg/87,5 mg harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard | Carbidopa, Levodopa | Netherlands | Authorised | 2026 |
| Kinemucil acetylcysteïne 600 mg bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2019 |
| MONUROL3GM BASE/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solution | Fosfomycin | United States | Not marketed | 1996 |
| PROMIXINSoluzione per nebulizzatore | Colistin | Italy | Authorised | |
| Respimucil 600 mg granule za oralnu otopinu u vrećiciGranule za oralnu otopinu u vrećici | Acetylcysteine | Croatia | Authorised | 2023 |
| Respimucil 600 mg šumeće tableteŠumeća tableta | Acetylcysteine | Croatia | Authorised | 2023 |
| Spidifen 200 mg tabletetableta | Ibuprofen | Croatia | Marketed | 2019 |
| Spidifen 400 mg filmom obložene tabletefilmom obložena tableta | Ibuprofen | Croatia | Marketed | 2019 |
| Tadim, 1 miljoen internationale eenheden (IE) poeder voor oplossing voor infusiePoeder voor oplossing voor infusie | Colistin | Netherlands | Authorised | 2011 |
| Tadim, 1 miljoen internationale eenheden (IE), poeder voor verneveloplossingPoeder voor verneveloplossing | Colistin | Netherlands | Authorised | 2010 |
| XADAGOCompressa rivestita con film | Safinamide | Italy | Authorised | |
| Xadago | Safinamide | EU (EMA) | Authorised | 2015 |
| Xadago 100 mg, tablettenTablet | Safinamide | Netherlands | Authorised | 2015 |
| Xadago 50 mg, tablettenTablet | Safinamide | Netherlands | Authorised | 2015 |
| FLUIMUCIL 20 mg/ml PEDIATRIC20mg/ml · Sol. orala | Acetylcysteine | Romania | unknown | |
| FLUIMUCIL 300 mg/3 ml300mg/3ml · Sol.inj./inhal.nebuliz./instilatie endotraheobron. | Acetylcysteine | Romania | unknown | |
| MONURAL 3 g3g/plic · Gran. pt. sol. orala | Fosfomycin | Romania | unknown | |
| MONURAL PEDIATRIC 2 g2g/plic · Gran. pt. sol. orala | Fosfomycin | Romania | unknown |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 10 | 10 | 0 | CompaniesAll medicines |
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
| Italy | 3 | 3 | 0 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Serbia, Singapore, Spain, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.